Centiva Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-425
| Closed | -$206K | – | 1727 |
|
|
2025
Q1 | $206K | Sell |
425
-832
| -66% | -$403K | 0.01% | 1105 |
|
|
2024
Q4 | $506K | Sell |
1,257
-1,768
| -58% | -$712K | 0.01% | 581 |
|
|
2024
Q3 | $1.41M | Buy |
3,025
+138
| +5% | +$64.2K | 0.03% | 341 |
|
|
2024
Q2 | $1.35M | Buy |
2,887
+579
| +25% | +$271K | 0.02% | 397 |
|
|
2024
Q1 | $965K | Buy |
2,308
+1,314
| +132% | +$549K | 0.02% | 445 |
|
|
2023
Q4 | $404K | Buy |
994
+484
| +95% | +$197K | 0.01% | 664 |
|
|
2023
Q3 | $177K | Sell |
510
-9,952
| -95% | -$3.46M | ﹤0.01% | 955 |
|
|
2023
Q2 | $3.68M | Buy |
10,462
+9,723
| +1,316% | +$3.42M | 0.08% | 129 |
|
|
2023
Q1 | $233K | Buy |
739
+314
| +74% | +$98.9K | 0.01% | 787 |
|
|
2022
Q4 | $123K | Sell |
425
-55
| -11% | -$15.9K | ﹤0.01% | 772 |
|
|
2022
Q3 | $139K | Buy |
+480
| New | +$139K | ﹤0.01% | 779 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1470 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1322 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1132 |
|
|
2021
Q3 | – | Sell |
-11,053
| Closed | -$2.23M | – | 1253 |
|
|
2021
Q2 | $2.23M | Buy |
11,053
+5,757
| +109% | +$1.16M | 0.05% | 120 |
|
|
2021
Q1 | $1.14M | Buy |
5,296
+1,615
| +44% | +$347K | 0.04% | 151 |
|
|
2020
Q4 | $870K | Buy |
3,681
+1,016
| +38% | +$240K | 0.03% | 178 |
|
|
2020
Q3 | $725K | Sell |
2,665
-2,176
| -45% | -$592K | 0.05% | 167 |
|
|
2020
Q2 | $1.41M | Buy |
4,841
+519
| +12% | +$151K | 0.08% | 68 |
|
|
2020
Q1 | $1.03M | Sell |
4,322
-8,552
| -66% | -$2.04M | 0.05% | 82 |
|
|
2019
Q4 | $2.82M | Sell |
12,874
-830
| -6% | -$182K | 0.14% | 26 |
|
|
2019
Q3 | $2.32M | Buy |
13,704
+12,496
| +1,034% | +$2.12M | 0.14% | 52 |
|
|
2019
Q2 | $221K | Sell |
1,208
-2,277
| -65% | -$417K | 0.01% | 110 |
|
|
2019
Q1 | $641K | Buy |
+3,485
| New | +$641K | 0.04% | 62 |
|